(*contributed equally to this work, § Technical contact) Published: Aug 20, 2023 DOI: 10.21769/BioProtoc.4844 Views: 786
Reviewed by: Anonymous reviewer(s)
In the Background section of “Establishment of Human PD-1/PD-L1 Blockade Assay Based on Surface Plasmon Resonance (SPR) Biosensor" (https://bio-protocol.org/e4765), “Alsaab et al., 2018” is incorrectly referenced. The correct citation is “Alsaab et al., 2017”. The sentence should read as follows: “Clinical data have demonstrated that the blockade of PD-1 or PD-L1 can boost T cell–mediated antitumor responses, generates durable clinical responses, and prolongs patient survival time (Ohaegbulam et al., 2015; Alsaab et al., 2017).”
Article Information
Copyright
© 2023 The Author(s); This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).
How to cite
Puopolo, T., Li, H., Gutkowski, J., Cai, A., Seeram, N. P., Ma, H. and Liu, C. (2023). Correction Notice: Establishment of Human PD-1/PD-L1 Blockade Assay Based on Surface Plasmon Resonance (SPR) Biosensor. Bio-protocol 13(16): e4844. DOI: 10.21769/BioProtoc.4844.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.